FIELD: medicine, pharmaceutics.
SUBSTANCE: invention refers to using a compound of formula (I):
wherein R represents a hydrogen atom or CH3, and X represents a physiologically acceptable counter ion for preparing a hepatoprotective agent for treating or preventing a liver injury. The invention also refers to a method for treating or preventing the liver injury which involves a therapeutically or preventive effective amount of said compound of formula (I).
EFFECT: declared group of inventions provides hepatoprotective activity ensured by an ability of the compounds of formula (I) to improve an endothelium function to release endogenic prostacyclin.
14 cl, 7 dwg, 3 tbl, 5 ex
| Title | Year | Author | Number |
|---|---|---|---|
| APPLICATION OF QUATERNARY PYRIDINIUM SALTS AS VASOPROTECTIVE AGENTS | 2005 |
|
RU2366420C2 |
| PHARMACEUTICAL FORMULATION FOR TREATING DISEASES ASSOCIATED WITH ENDOTHELIAL DYSFUNCTION | 2012 |
|
RU2504375C1 |
| THERAPEUTIC DRUG FOR DISEASES RELATED TO ENDOPLASMIC RETICULUM CELL DEATH IN CORNEAL ENDOTHELIUM | 2014 |
|
RU2712967C2 |
| USE OF ICARITIN FOR OBTAINING MEDICINAL PRODUCTS | 2021 |
|
RU2806093C1 |
| METHOD OF TREATING PATIENTS WITH CHRONIC GLOMERULONEPHRITIS COMBINED WITH CHRONIC OPISTHORCHIASIS | 2010 |
|
RU2417081C1 |
| ACIDIFIED ARYLCYCLOALKYLAMINS AND THEIR APPLICATION AS PHARMACEUTICAL DRUGS | 2003 |
|
RU2337094C2 |
| METHOD OF TREATMENT OF ENDOTHELIAL DYSFUNCTION | 2017 |
|
RU2657416C1 |
| AGENT FOR TREATING PULMONARY HYPERTENSION | 2023 |
|
RU2813890C1 |
| METHOD OF EVALUATION OF DEGREE OF ENDOTHELIAL DYSFUNCTION | 2007 |
|
RU2324939C1 |
| METHOD OF PREVENTING ENDOTHELIAL DAMAGE IN CRITICALLY ILL PATIENTS | 2023 |
|
RU2812594C1 |
